International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial
11 juin 2018 07h00 HE
|
International Stem Cell Corporation
CARLSBAD, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...